Syntara Limited has released a press release.
$8m placement and share purchase plan
Earlier from Syntara
- Continuation of trading halt
- Positive FDA feedback for Amsulostat P2b trial
- Half Year Report and Appendix 4D
- Quarterly Activities/Appendix 4C Cash Flow Report